130 related articles for article (PubMed ID: 27359314)
1. [Desoxypipradrol - a new (already well known) designer drug].
Müller D; Angerer V; Kithinji J; Auwärter V; Neurath H; Liebetrau G; Just S; Hermanns-Clausen M
Dtsch Med Wochenschr; 2016 Jul; 141(13):951-3. PubMed ID: 27359314
[TBL] [Abstract][Full Text] [Related]
2. Novel psychoactive substances.
Krabseth HM; Tuv SS; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
Tidsskr Nor Laegeforen; 2016 May; 136(8):714-7. PubMed ID: 27143461
[TBL] [Abstract][Full Text] [Related]
3. [Party drugs cause dangerous poisonings. Risk of serious complications and death].
Knudsen K
Lakartidningen; 2011 Feb 2-8; 108(5):207-11. PubMed ID: 21384618
[No Abstract] [Full Text] [Related]
4. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
Coppola M; Mondola R
Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
[TBL] [Abstract][Full Text] [Related]
5. [New psychoactive substances and their prevalence in the Czech Republic].
Mravčík V; Běláčková V; Grohmannová K; Zábranský T
Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of the use of designer drugs in Poland--review of the published evidence.
Kryska S
Przegl Epidemiol; 2016; 70(1):35-9, 121-3. PubMed ID: 27344472
[TBL] [Abstract][Full Text] [Related]
7. New designer drugs from the web.
Tuv SS; Krabseth HM; Strand MC; Karinen RA; Wiik E; Vevelstad MS; Westin AA; Øiestad EL; Vindenes V
Tidsskr Nor Laegeforen; 2016 May; 136(8):721-3. PubMed ID: 27143463
[No Abstract] [Full Text] [Related]
8. [MT-45--a dangerous and potentially ototoxic internet drug].
Lindeman E; Bäckberg M; Personne M; Helander A
Lakartidningen; 2014 Sep; 111(40):1712-5. PubMed ID: 25253604
[TBL] [Abstract][Full Text] [Related]
9. [Poisoning with amphetamines and designer drugs].
Felgenhauer N; Zilker T
Internist (Berl); 1999 Jun; 40(6):617-23. PubMed ID: 10420315
[No Abstract] [Full Text] [Related]
10. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
Liechti M
Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of intoxication with novel psychoactive substance (NPS) in Pomeranian region, from January to July 2015].
Kabata P; Schetz D; Waldman W; Wiergowsk M; Sein Anand J
Przegl Lek; 2015; 72(10):517-21. PubMed ID: 26946558
[TBL] [Abstract][Full Text] [Related]
12. Flubromazolam--A new life-threatening designer benzodiazepine.
Łukasik-Głębocka M; Sommerfeld K; Teżyk A; Zielińska-Psuja B; Panieński P; Żaba C
Clin Toxicol (Phila); 2016; 54(1):66-8. PubMed ID: 26585557
[TBL] [Abstract][Full Text] [Related]
13. [The influx of deadly internet drugs continue].
Helander A
Lakartidningen; 2016 Sep; 113():. PubMed ID: 27701675
[No Abstract] [Full Text] [Related]
14. A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan.
Kamijo Y; Takai M; Fujita Y; Hirose Y; Iwasaki Y; Ishihara S; Yokoyama T; Yagi K; Sakamoto T
Intern Med; 2014; 53(21):2439-45. PubMed ID: 25366001
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.
Helander A; Bäckberg M
Handb Exp Pharmacol; 2018; 252():461-473. PubMed ID: 30135990
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine.
Hofer KE; Degrandi C; Müller DM; Zürrer-Härdi U; Wahl S; Rauber-Lüthy C; Ceschi A
Clin Toxicol (Phila); 2014 Dec; 52(10):1288-91. PubMed ID: 25350467
[TBL] [Abstract][Full Text] [Related]
17. Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.
Helander A; Bäckberg M; Signell P; Beck O
Clin Toxicol (Phila); 2017 Jul; 55(6):589-599. PubMed ID: 28349714
[TBL] [Abstract][Full Text] [Related]
18. Severe clinical toxicity caused by 25I-NBOMe confirmed analytically using LC-MS-MS method.
Waldman W; Kała M; Lechowicz W; Gil D; Anand JS
Acta Biochim Pol; 2018 Oct; 65(4):567-571. PubMed ID: 30335087
[TBL] [Abstract][Full Text] [Related]
19. 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
Smith CD; Robert S
Clin Med (Lond); 2014 Aug; 14(4):409-15. PubMed ID: 25099844
[TBL] [Abstract][Full Text] [Related]
20. New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.
Schifano F; Chiappini S; Miuli A; Corkery JM; Scherbaum N; Napoletano F; Arillotta D; Zangani C; Catalani V; Vento A; Pettorruso M; Martinotti G; Massimo DG; Guirguis A
Exp Neurol; 2021 May; 339():113638. PubMed ID: 33571533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
